Half year summary of NATUREX’s liquidity contract with NATIXIS
Press release
Avignon, January 4th, 2012
Pursuant to the liquidity contract granted to NATIXIS the following elements were in the liquidity account as of December 31st, 2011:
- 4,660 NATUREX shares
- 145,664.01 euros
For information, the following elements appeared on the liquidity account at the time of the implementation of the liquidity contract:
- 923 NATUREX shares
- 277,801.85 euros
Download our press releases and other publications on www.naturex.com
Naturex has been listed since October 1996 on NYSE Euronext Paris, Compartment B (MidCaps)
Number of shares comprising the capital:7,705,580
Naturex is eligible for "long only" Deferred Settlement Service (SRD). Naturex has implemented a Sponsored Level I American Depositary Receipt (ADR) program, which trades on over-the-counter market in the United States under symbol NTUXY. TICKER: NRX - Reuters : NATU.PA - Bloomberg : NRX:FP - DR Symbol: NTUXY |
About Naturex
NATUREX is a global leader in specialty plant-based natural ingredients.
The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
NATUREX’s head office is based in Avignon, France. The company employs more than 1,000 people with high-performance manufacturing operations across 14 sites in Europe (France, Italy, Spain, the United Kingdom, Switzerland, Poland), as well as in Morocco, the United States, Brazil and Australia. It also has a global presence through a dedicated network of sales offices in 19 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Poland, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, the United States, Canada, Brazil and Mexico).
NATUREX's development is supported by positive underlying trends linked to a fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.
- Contacts
| Jacques Dikansky President and Chief Executive Officer Tel.: +33 (0)4 90 23 96 89 naturex@naturex.com Carole Alexandre Investor Relations Tel.: +33 (0)4 90 23 78 28 c.alexandre@naturex.com |
Thierry Lambert Vice-President and Chief Financial Officer Tel.: +33 (0)4 90 23 96 89 t.lambert@naturex.com Anne Catherine Bonjour Actus Finance Press Relations Tel.: +33 (0)1 53 67 36 93 acbonjour@actus.fr |
